首页> 美国卫生研究院文献>G3: GenesGenomesGenetics >Copy Number Profiling of Brazilian Astrocytomas
【2h】

Copy Number Profiling of Brazilian Astrocytomas

机译:巴西星形细胞瘤的副本编号分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Copy number alterations (CNA) are one of the driving mechanisms of glioma tumorigenesis, and are currently used as important biomarkers in the routine setting. Therefore, we performed CNA profiling of 65 astrocytomas of distinct malignant grades (WHO grade I–IV) of Brazilian origin, using array-CGH and microsatellite instability analysis (MSI), and investigated their correlation with TERT and IDH1 mutational status and clinico-pathological features. Furthermore, in silico analysis using the Oncomine database was performed to validate our findings and extend the findings to gene expression level. We found that the number of genomic alterations increases in accordance with glioma grade. In glioblastomas (GBM), the most common alterations were gene amplifications (PDGFRA, KIT, KDR, EGFR, and MET) and deletions (CDKN2A and PTEN). Log-rank analysis correlated EGFR amplification and/or chr7 gain with better survival of the patients. MSI was observed in 11% of GBMs. A total of 69% of GBMs presented TERT mutation, whereas IDH1 mutation was most frequent in diffuse (85.7%) and anaplastic (100%) astrocytomas. The combination of 1p19q deletion and TERT and IDH1 mutational status separated tumor groups that showed distinct age of diagnosis and outcome. In silico validation pointed to less explored genes that may be worthy of future investigation, such as CDK2, DMRTA1, and MTAP. Herein, using an extensive integrated analysis, we indicated potentially important genes, not extensively studied in gliomas, that could be further explored to assess their biological and clinical impact in astrocytomas.
机译:拷贝数改变(CNA)是神经胶质瘤肿瘤发生的驱动机制之一,目前在常规环境中被用作重要的生物标志物。因此,我们使用阵列CGH和微卫星不稳定性分析(MSI)对65种巴西起源的不同恶性级别(WHO I–IV级)星形细胞瘤进行了CNA分析,并研究了它们与TERT和IDH1突变状态以及临床病理的相关性特征。此外,使用Oncomine数据库进行了计算机分析,以验证我们的发现并将发现扩展到基因表达水平。我们发现,基因组改变的数目根据神经胶质瘤等级而增加。在胶质母细胞瘤(GBM)中,最常见的改变是基因扩增(PDGFRA,KIT,KDR,EGFR和MET)和缺失(CDKN2A和PTEN)。对数秩分析将EGFR扩增和/或chr7增益与患者更好的存活率相关。在11%的GBM中观察到MSI。共有69%的GBM出现TERT突变,而IDH1突变最常见于弥漫性星形胶质瘤(85.7%)和间变性星形胶质瘤(100%)。 1p19q缺失与TERT和IDH1突变状态的组合将显示出不同诊断年龄和预后的肿瘤组分开。在计算机验证中,指出了较少探索的基因,可能值得将来研究,例如 CDK2 DMRTA1 MTAP 。在这里,我们使用广泛的综合分析,指出了潜在的重要基因,尚未在神经胶质瘤中广泛研究,可以进一步探索以评估其对星形细胞瘤的生物学和临床影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号